Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

~18 mi. (Würzburg, Germany, +130 more cities)

Universitaetsklinikum Wuerzburg ( Site 0265)

Bladder Urothelial Carcinoma

BCG solution, +1 more drug

immunotherapy

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

~18 mi. (Würzburg, Germany, +199 more cities)

Universitaetsklinikum Wuerzburg ( Site 0468)

Hepatocellular Carcinoma

pembrolizumab

immunotherapy

A Study of LOXO-292 in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer

~18 mi. (Würzburg, Germany, +78 more cities)

Universitätsklinikum Würzburg A. ö. R.

RET Fusion, +1 more biomarker

Adrenal Gland Pheochromocytoma, +5 more conditions

selpercatinib

targeted therapy

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

~18 mi. (Würzburg, Germany, +141 more cities)

GSK Investigational Site

Multiple Myeloma

belantamab mafodotin

chemotherapy, +1 more type

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

~18 mi. (Würzburg, Germany, +143 more cities)

Universitätsklinikum Würzburg A. ö. R.

RET Mutation

Thyroid Gland Medullary Carcinoma

selpercatinib

targeted therapy

Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

~18 mi. (Würzburg, Germany, +74 more cities)

GSK Investigational Site

Multiple Myeloma

belantamab mafodotin, +3 more drugs

chemotherapy, +2 more types

Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

~18 mi. (Würzburg, Germany, +18 more cities)

Universitätsklinikum Würzburg - Klinik für Dermatologie, Venerologie und Allergologie

Cutaneous Melanoma

nivolumab

immunotherapy

Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

~18 mi. (Würzburg, Germany, +6 more cities)

University Hospital Department of Ophtalmology

Monosomy 3

Uveal Melanoma

therapeutic autologous dendritic cells

cellular therapy, +1 more type

Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies

~18 mi. (Würzburg, Germany, +5 more cities)

Universitätsklinikum Würzburg

IL3RA Expression

Acute Myeloid Leukemia, +2 more conditions

cyclophosphamide, +2 more drugs

chemotherapy, +1 more type

TCR-engineered T Cells in Solid Tumors: IMA202-101

~18 mi. (Würzburg, Germany, +8 more cities)

Universitätsklinikum Würzburg

MAGEA1 Expression

Malignant Solid Tumor

aldesleukin, +3 more drugs

cellular therapy, +3 more types

TCR-engineered T Cells in Solid Tumors

~18 mi. (Würzburg, Germany, +7 more cities)

Universitätsklinikum Würzburg

Malignant Solid Tumor

aldesleukin, +4 more drugs

cellular therapy, +3 more types

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

~18 mi. (Würzburg, Germany)

University Children's Hospital

Malignant Glioma

cyclophosphamide, +3 more drugs

cellular therapy, +2 more types